Concepedia

Ana P. Lacerda

AP

Statistics

Publications

21

Citations

1.5K

H-Index

16

Active since

2008

Affiliations

AbbVie (United States)(Current)

University of California San Diego

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

University of Calgary

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer

Ana P. Lacerda is an author at AbbVie (United States) specializing in medicine, gastroenterology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2008–2024

21

Publications

21

Upadacitinib Induction and Maintenance Therapy for Crohn’s Disease

Edward V. Loftus, Julián Panés, Ana P. Lacerda et al. · New England Journal of Medicine · 2023 · 373 citations · Full text

Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn’s Disease

William J. Sandborn, Brian G. Feagan, Edward V. Loftus et al. · Gastroenterology · 2020 · 302 citations · Full text

Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis

Gerd R Burmester, Stanley Cohen, Kevin Winthrop et al. · RMD Open · 2023 · 185 citations · Full text

Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis

Gerd R Burmester, Robert Landewé, Mark C. Genovese et al. · Annals of the Rheumatic Diseases · 2016 · 107 citations · Full text

Safety and Efficacy of ABT-494 (Upadacitinib), an Oral Jak1 Inhibitor, as Induction Therapy in Patients with Crohn's Disease: Results from Celest

William J. Sandborn, Brian G. Feagan, Julián Panés et al. · Gastroenterology · 2017 · 85 citations

, , +9

1–5 of 21